583 related articles for article (PubMed ID: 34399607)
1. Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.
Merenstein C; Liang G; Whiteside SA; Cobián-Güemes AG; Merlino MS; Taylor LJ; Glascock A; Bittinger K; Tanes C; Graham-Wooten J; Khatib LA; Fitzgerald AS; Reddy S; Baxter AE; Giles JR; Oldridge DA; Meyer NJ; Wherry EJ; McGinniss JE; Bushman FD; Collman RG
mBio; 2021 Aug; 12(4):e0177721. PubMed ID: 34399607
[TBL] [Abstract][Full Text] [Related]
2. Signatures of COVID-19 severity and immune response in the respiratory tract microbiome.
Merenstein C; Liang G; Whiteside SA; Cobián-Güemes AG; Merlino MS; Taylor LJ; Glascock A; Bittinger K; Tanes C; Graham-Wooten J; Khatib LA; Fitzgerald AS; Reddy S; Baxter AE; Giles JR; Oldridge DA; Meyer NJ; Wherry EJ; McGinniss JE; Bushman FD; Collman RG
medRxiv; 2021 Apr; ():. PubMed ID: 33851179
[TBL] [Abstract][Full Text] [Related]
3. Oral Microbiome Alterations and SARS-CoV-2 Saliva Viral Load in Patients with COVID-19.
Miller EH; Annavajhala MK; Chong AM; Park H; Nobel YR; Soroush A; Blackett JW; Krigel A; Phipps MM; Freedberg DE; Zucker J; Sano ED; Uhlemann AC; Abrams JA
Microbiol Spectr; 2021 Oct; 9(2):e0005521. PubMed ID: 34643448
[TBL] [Abstract][Full Text] [Related]
4. Upper Respiratory Dysbiosis with a Facultative-dominated Ecotype in Advanced Lung Disease and Dynamic Change after Lung Transplant.
Simon-Soro A; Sohn MB; McGinniss JE; Imai I; Brown MC; Knecht VR; Bailey A; Clarke EL; Cantu E; Li H; Bittinger K; Diamond JM; Christie JD; Bushman FD; Collman RG
Ann Am Thorac Soc; 2019 Nov; 16(11):1383-1391. PubMed ID: 31415219
[No Abstract] [Full Text] [Related]
5. Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients.
de Castilhos J; Zamir E; Hippchen T; Rohrbach R; Schmidt S; Hengler S; Schumacher H; Neubauer M; Kunz S; Müller-Esch T; Hiergeist A; Gessner A; Khalid D; Gaiser R; Cullin N; Papagiannarou SM; Beuthien-Baumann B; Krämer A; Bartenschlager R; Jäger D; Müller M; Herth F; Duerschmied D; Schneider J; Schmid RM; Eberhardt JF; Khodamoradi Y; Vehreschild MJGT; Teufel A; Ebert MP; Hau P; Salzberger B; Schnitzler P; Poeck H; Elinav E; Merle U; Stein-Thoeringer CK
Clin Infect Dis; 2022 Aug; 75(1):e1063-e1071. PubMed ID: 34694375
[TBL] [Abstract][Full Text] [Related]
6. Temporal dynamics of oropharyngeal microbiome among SARS-CoV-2 patients reveals continued dysbiosis even after Viral Clearance.
Paine SK; Rout UK; Bhattacharyya C; Parai D; Alam M; Nanda RR; Tripathi D; Choudhury P; Kundu CN; Pati S; Bhattacharya D; Basu A
NPJ Biofilms Microbiomes; 2022 Aug; 8(1):67. PubMed ID: 36002454
[TBL] [Abstract][Full Text] [Related]
7. Limited Impact of SARS-CoV-2 on the Human Naso-Oropharyngeal Microbiota in Hospitalized Patients.
Lai CKC; Cheung MK; Lui GCY; Ling L; Chan JYK; Ng RWY; Chan HC; Yeung ACM; Ho WCS; Boon SS; Chan PKS; Chen Z
Microbiol Spectr; 2022 Dec; 10(6):e0219622. PubMed ID: 36350127
[TBL] [Abstract][Full Text] [Related]
8. Oropharyngeal microbial ecosystem perturbations influence the risk for acute respiratory infections in common variable immunodeficiency.
Pulvirenti F; Giufrè M; Pentimalli TM; Camilli R; Milito C; Villa A; Sculco E; Cerquetti M; Pantosti A; Quinti I
Front Immunol; 2024; 15():1371118. PubMed ID: 38873612
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
[TBL] [Abstract][Full Text] [Related]
10. Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19.
Schult D; Reitmeier S; Koyumdzhieva P; Lahmer T; Middelhoff M; Erber J; Schneider J; Kager J; Frolova M; Horstmann J; Fricke L; Steiger K; Jesinghaus M; Janssen KP; Protzer U; Neuhaus K; Schmid RM; Haller D; Quante M
Gut Microbes; 2022; 14(1):2031840. PubMed ID: 35174781
[TBL] [Abstract][Full Text] [Related]
11. Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients.
Qin T; Wang Y; Deng J; Xu B; Zhu X; Wang J; Zhou H; Zhao N; Jin F; Ren H; Wang H; Li Q; Xu X; Guo Y; Li R; Xiong Y; Wang X; Guo J; Zheng H; Hou X; Wan K; Zhang J; Lu J; Kan B; Xu J
Microbiol Spectr; 2022 Jun; 10(3):e0195621. PubMed ID: 35579467
[TBL] [Abstract][Full Text] [Related]
12. Dysbiosis and structural disruption of the respiratory microbiota in COVID-19 patients with severe and fatal outcomes.
Hernández-Terán A; Mejía-Nepomuceno F; Herrera MT; Barreto O; García E; Castillejos M; Boukadida C; Matias-Florentino M; Rincón-Rubio A; Avila-Rios S; Mújica-Sánchez M; Serna-Muñoz R; Becerril-Vargas E; Guadarrama-Pérez C; Ahumada-Topete VH; Rodríguez-Llamazares S; Martínez-Orozco JA; Salas-Hernández J; Pérez-Padilla R; Vázquez-Pérez JA
Sci Rep; 2021 Oct; 11(1):21297. PubMed ID: 34716394
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 infection reduces human nasopharyngeal commensal microbiome with inclusion of pathobionts.
Hoque MN; Sarkar MMH; Rahman MS; Akter S; Banu TA; Goswami B; Jahan I; Hossain MS; Shamsuzzaman AKM; Nafisa T; Molla MMA; Yeasmin M; Ghosh AK; Osman E; Alam SKS; Uzzaman MS; Habib MA; Mahmud ASM; Crandall KA; Islam T; Khan MS
Sci Rep; 2021 Dec; 11(1):24042. PubMed ID: 34911967
[TBL] [Abstract][Full Text] [Related]
14. Metagenomic Next-Generation Sequencing of Nasopharyngeal Specimens Collected from Confirmed and Suspect COVID-19 Patients.
Mostafa HH; Fissel JA; Fanelli B; Bergman Y; Gniazdowski V; Dadlani M; Carroll KC; Colwell RR; Simner PJ
mBio; 2020 Nov; 11(6):. PubMed ID: 33219095
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Altered Oropharyngeal Microbiota in Hospitalized Patients With Mild SARS-CoV-2 Infection.
Shi YL; He MZ; Han MZ; Gui HY; Wang P; Yu JL; Ge YL; Sun Y; Huang SH
Front Cell Infect Microbiol; 2022; 12():824578. PubMed ID: 35372134
[TBL] [Abstract][Full Text] [Related]
16. Diversity, composition, and networking of saliva microbiota distinguish the severity of COVID-19 episodes as revealed by an analysis of 16S rRNA variable V1-V3 region sequences.
Larios Serrato V; Meza B; Gonzalez-Torres C; Gaytan-Cervantes J; González Ibarra J; Santacruz Tinoco CE; Anguiano Hernández YM; Martínez Miguel B; Cázarez Cortazar A; Sarquiz Martínez B; Alvarado Yaah JE; Mendoza Pérez AR; Palma Herrera JJ; García Soto LM; Chávez Rojas AI; Bravo Mateos G; Samano Marquez G; Grajales Muñiz C; Torres J
mSystems; 2023 Aug; 8(4):e0106222. PubMed ID: 37310423
[TBL] [Abstract][Full Text] [Related]
17. The lower respiratory tract microbiome of critically ill patients with COVID-19.
Gaibani P; Viciani E; Bartoletti M; Lewis RE; Tonetti T; Lombardo D; Castagnetti A; Bovo F; Horna CS; Ranieri M; Viale P; Re MC; Ambretti S
Sci Rep; 2021 May; 11(1):10103. PubMed ID: 33980943
[TBL] [Abstract][Full Text] [Related]
18. The salivary and nasopharyngeal microbiomes are associated with SARS-CoV-2 infection and disease severity.
Kim JG; Zhang A; Rauseo AM; Goss CW; Mudd PA; O'Halloran JA; Wang L
J Med Virol; 2023 Feb; 95(2):e28445. PubMed ID: 36583481
[TBL] [Abstract][Full Text] [Related]
19. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
[TBL] [Abstract][Full Text] [Related]
20. Composition and dynamics of the respiratory tract microbiome in intubated patients.
Kelly BJ; Imai I; Bittinger K; Laughlin A; Fuchs BD; Bushman FD; Collman RG
Microbiome; 2016 Feb; 4():7. PubMed ID: 26865050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
